3 ETFs That Historically Perform Well in the Final Weeks of May

The article highlights three seasonal ETF ideas for late May: Invesco NASDAQ 100 ETF (QQQM), State Street Consumer Staples Select Sector SPDR ETF (XLP), and Vanguard Health Care ETF (VHT). It cites historical May strength for the Nasdaq-100 (+1.6% average in May), consumer staples' favorable stretch from late April through Thanksgiving, and healthcare's seasonal support heading into summer. The piece is advisory and defensive in tone rather than event-driven, so near-term market impact is limited.

Analysis

Seasonality is being used here as a timing tool, but the more important signal is factor rotation: the article is implicitly recommending a move away from crowded mega-cap growth and into lower-beta cash-generative defenses. That matters because the market’s AI concentration has made index-level tech exposure more fragile than the headline tape suggests; if leadership broadens even modestly, the marginal buyer is likely to favor staples and healthcare before it adds more Nasdaq beta.

QQQM is the highest-beta expression of the setup, but it also carries the most timing risk. The second-order issue is June seasonality: if late-May strength fades, the same crowd that chases momentum into tech can unwind quickly, making this more of a tactical trade than a durable allocation unless earnings revisions stay intact. For the next 2-6 weeks, the better risk-adjusted opportunity is probably not outright tech, but a relative-value stance versus defensive sectors that are already behaving well.

XLP and VHT look like the cleaner defensive expression because they benefit from two overlapping forces: reduced appetite for cyclical exposure and the ongoing desire to own non-AI earnings streams. The healthcare call is particularly interesting because the article’s seasonal framing overlooks a key catalyst stack: pharma-heavy names have idiosyncratic pipeline and regulatory events that can decouple the group from the market, so a passive allocation can quietly outperform if growth leadership weakens. The contrarian risk is that if index breadth improves and rates back up, defensives can lag even while QQQM still works on a tactical basis.

The miss in the piece is that this is less about "May" and more about positioning into a potential summer leadership transition. If tech earnings breadth stays narrow, the upside in QQQM may be capped by profit-taking; if not, staples and healthcare could outperform simply because investors are underweight duration and overexposed to AI-linked consensus winners.

Key Decisions for Investors

• Long XLP vs. QQQM for the next 2-6 weeks: best risk/reward if market breadth remains narrow; use a tight stop if the Nasdaq-100 re-accelerates on earnings revisions.
• Initiate a tactical long in VHT into summer, with a 1-3 month horizon: lower correlation to the AI crowd and better downside capture than broad equity if volatility rises.
• If buying QQQM, do it as a short-dated momentum trade only: consider call spreads into late May/early June, then reduce exposure before the seasonally weak June window.
• Pair trade idea: long VHT / short a basket of AI-heavy mega-cap proxies for a relative-value hedge if the market starts rewarding earnings quality over narrative.
• For defensive allocators, scale into XLP on any pullback rather than chasing strength: the setup is more about steady compounding than breakout upside, with lower drawdown risk if sentiment deteriorates.